Gefitinib, an EGFR Tyrosine Kinase inhibitor, Prevents Smoke-Mediated Ciliated Airway Epithelial Cell Loss and Promotes Their Recovery

Open Access

Peer-reviewed

Research Article

Monica Valencia-Gattas,

Affiliation Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
⨯
Gregory E. Conner,

Affiliation Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
⨯
Nevis L. Fregien

* E-mail: Nevis@miami.edu

Affiliation Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
⨯

Reader Comments (0)

Smoking habits
Is the Subject Area "Smoking habits" applicable to this article?

Thanks for your feedback.
Cell differentiation
Is the Subject Area "Cell differentiation" applicable to this article?

Thanks for your feedback.
Smoking related disorders
Is the Subject Area "Smoking related disorders" applicable to this article?

Thanks for your feedback.
EGFR signaling
Is the Subject Area "EGFR signaling" applicable to this article?

Thanks for your feedback.
Epithelial cells
Is the Subject Area "Epithelial cells" applicable to this article?

Thanks for your feedback.
Signal inhibition
Is the Subject Area "Signal inhibition" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.
Lung development
Is the Subject Area "Lung development" applicable to this article?

Thanks for your feedback.